The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults

Achievement of Healthy People 2010 Objective for Adult Pneumococcal Vaccination in an American Indian Community

(2017) Marc S. Traeger et al.   PUBLIC HEALTH REPORTS

The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations

(2011) Maria A. Said et al.   VACCINE

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults

(2010) Maria Peñaranda et al.   AIDS

Pneumococcal Polysaccharide Vaccination Among Adults Aged 65 Years and Older, U.S., 1989–2008

(2010) Peng-jun Lu et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Exposure to Children as a Risk Factor for Bacteremic Pneumococcal Disease

(2010) Joshua P. Metlay   ARCHIVES OF INTERNAL MEDICINE

High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya

(2010) Daniel R Feikin et al.   BMC INFECTIOUS DISEASES

Determining the Optimal Pneumococcal Vaccination Strategy for Adults

(2010) Mark L. Metersky et al.   CHEST

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

(2010) S. Esposito et al.   Clinical and Vaccine Immunology

Invasive Pneumococcal Disease a Decade after Pneumococcal Conjugate Vaccine Use in an American Indian Population at High Risk for Disease

(2010) Robert Weatherholtz et al.   CLINICAL INFECTIOUS DISEASES

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

(2010) Deborah Lehmann et al.   CLINICAL INFECTIOUS DISEASES

Sickle Cell Trait, Hemoglobin C Trait, and Invasive Pneumococcal Disease

(2010) Katherine A. Poehling et al.   EPIDEMIOLOGY

Factors associated with pneumococcal and influenza vaccination in hospitalized people aged ⩾65 years

(2010) X. SINTES et al.   EPIDEMIOLOGY AND INFECTION

Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies

(2010) A. WONG et al.   EPIDEMIOLOGY AND INFECTION

The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review

(2010) RH Pedersen et al.   HIV MEDICINE

Hospitalizations for Invasive Pneumococcal Disease Among HIV-1–Infected Adolescents and Adults in the United States in the Era of Highly Active Antiretroviral Therapy and the Conjugate Pneumococcal Vaccine

(2010) Athena P Kourtis et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Association of Serotypes of Streptococcus pneumoniae with Age in Invasive Pneumococcal Disease

(2010) M. Imohl et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV‐Infected Adults

(2010) Nancy F. Crum‐Cianflone et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults

(2010) Daniel M. Musher et al.   JOURNAL OF INFECTIOUS DISEASES

Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years

(2010) Susan B. Manoff et al.   JOURNAL OF INFECTIOUS DISEASES

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults

(2010) Neil French et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months

(2010) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

(2010) Matthew D. Snape et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE

(2010) Corinne Levy et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

(2010)   PEDIATRICS

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine

(2010) K. A. Bryant et al.   PEDIATRICS

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers

(2010) S. H. Yeh et al.   PEDIATRICS

Burden of Community-Acquired Pneumonia in North American Adults

(2010) Thomas M. File et al.   POSTGRADUATE MEDICINE

Risk of invasive pneumococcal infections among working age adults with asthma

(2010) P. Klemets et al.   THORAX

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

(2010) Catherine Cordonnier et al.   VACCINE

Clinical and economic burden of pneumococcal disease in older US adults

(2010) Derek Weycker et al.   VACCINE

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

(2010) Dorothee M. Kieninger et al.   VACCINE

Pneumococcal disease caused by serotype 19A: Review of the literature and implications for future vaccine development

(2010) Rene Reinert et al.   VACCINE

Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease

(2009) Gil Y Melmed et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease

(2009) Mark T. Dransfield et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55–70 Years of Age

(2009) Karen M. Miernyk et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal Conjugate Vaccine, Polysaccharide Vaccine, or Both for Adults? We’re Not There Yet

(2009) Katherine L. O’Brien   CLINICAL INFECTIOUS DISEASES

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

(2009) David Goldblatt et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal conjugated vaccine: PHiD-CV

(2009) Ener Cagri Dinleyici et al.   Expert Review of Anti-Infective Therapy

Experience with pneumococcal conjugate vaccine in Norway

(2009) Ingeborg S Aaberge   Expert Review of Vaccines

10-valent pneumococcal nontypeableHaemophilus influenzaePD conjugate vaccine: Synflorix™

(2009) Roman Prymula et al.   Expert Review of Vaccines

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)

(2009) Markus Knuf et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

(2009) Simon Rückinger et al.   VACCINE

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007

(2009) Julie A. Bettinger et al.   VACCINE

Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance

(2008) D Kumar et al.   BONE MARROW TRANSPLANTATION

A Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Prime‐Boost Strategy for Pneumococcal Vaccination in Adult Liver Transplant Recipients

(2008) Deepali Kumar et al.   CLINICAL INFECTIOUS DISEASES

Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection

(2008) Lisa A. Jackson et al.   CLINICAL INFECTIOUS DISEASES

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

(2008) Andrés de Roux et al.   CLINICAL INFECTIOUS DISEASES

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

(2008) Daniel Scott et al.   PEDIATRICS INTERNATIONAL

Immunological responses to pneumococcal vaccine in frail older people

(2008) I. Ridda et al.   VACCINE

Pneumococcal Vaccination for Patients With COPD

(2007) Jeremy G. Schenkein et al.   CHEST